SEPT11
From Wikipedia, the free encyclopedia
Septin 11
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | SEPT11; | |||||||||||||
External IDs | MGI: 1277214 HomoloGene: 56800 | |||||||||||||
|
||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 55752 | 52398 | ||||||||||||
Ensembl | ENSG00000138758 | ENSMUSG00000058013 | ||||||||||||
Uniprot | Q9NVA2 | Q3TBA0 | ||||||||||||
Refseq | NM_018243 (mRNA) NP_060713 (protein) |
NM_001009818 (mRNA) NP_001009818 (protein) |
||||||||||||
Location | Chr 4: 78.09 - 78.18 Mb | Chr 5: 94.17 - 94.25 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Septin 11, also known as SEPT11, is a human gene.[1]
[edit] References
[edit] Further reading
- Andersen JS, Lyon CE, Fox AH, et al. (2002). "Directed proteomic analysis of the human nucleolus.". Curr. Biol. 12 (1): 1-11. PMID 11790298.
- Wistow G, Bernstein SL, Wyatt MK, et al. (2002). "Expressed sequence tag analysis of human RPE/choroid for the NEIBank Project: over 6000 non-redundant transcripts, novel genes and splice variants.". Mol. Vis. 8: 205-20. PMID 12107410.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Gevaert K, Goethals M, Martens L, et al. (2004). "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.". Nat. Biotechnol. 21 (5): 566-9. doi: . PMID 12665801.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi: . PMID 14702039.
- Kojima K, Sakai I, Hasegawa A, et al. (2004). "FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23).". Leukemia 18 (5): 998-1005. doi: . PMID 14999297.
- Kim DS, Hubbard SL, Peraud A, et al. (2004). "Analysis of mammalian septin expression in human malignant brain tumors.". Neoplasia 6 (2): 168-78. doi: . PMID 15140406.
- Hanai N, Nagata K, Kawajiri A, et al. (2004). "Biochemical and cell biological characterization of a mammalian septin, Sept11.". FEBS Lett. 568 (1-3): 83-8. doi: . PMID 15196925.
- Nagata K, Asano T, Nozawa Y, Inagaki M (2005). "Biochemical and cell biological analyses of a mammalian septin complex, Sept7/9b/11.". J. Biol. Chem. 279 (53): 55895-904. doi: . PMID 15485874.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi: . PMID 15489334.
- Andersen JS, Lam YW, Leung AK, et al. (2005). "Nucleolar proteome dynamics.". Nature 433 (7021): 77-83. doi: . PMID 15635413.
- Sudo K, Ito H, Iwamoto I, et al. (2007). "SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling.". Hum. Mutat. 28 (10): 1005-13. doi: . PMID 17546647.
- Xin X, Pache M, Zieger B, et al. (2007). "Septin expression in proliferative retinal membranes.". J. Histochem. Cytochem. 55 (11): 1089-94. doi: . PMID 17625225.